文献速递神经头颈儿科影像MR

MRI特征预测视网膜母细胞瘤患者静脉化疗疗效

MRI features for prediction of the intravenous chemotherapy effect in patients with retinoblastoma.
PubMed 文献 · Clin Radiol · 2023-08-03

回顾性纳入80例视网膜母细胞瘤患者共100只眼的治疗前临床与MRI资料,按静脉化疗疗效分为有效组59只眼和无效组41只眼。多因素回归显示侧别、边缘及眼前段强化为独立预测因素,联合三者的预测模型AUC为0.732(95%CI:0.633,0.831,p<0.01),敏感度71.2%,特异度70.7%。

要点

  • 侧别、边缘及眼前段强化是预测静脉化疗疗效的独立因素。
  • 联合上述三个MRI特征的预测模型AUC为0.732,敏感度71.2%,特异度70.7%。
  • 治疗前眼眶MRI特征可用于预测视网膜母细胞瘤静脉化疗疗效。

核心结论

  • 眼眶MRI特征可在视网膜母细胞瘤患者治疗前用于预测静脉化疗疗效。

研究设计与样本

  • 回顾性收集80例视网膜母细胞瘤患者共100只眼接受静脉化疗前的临床与MRI资料,有效组59只眼、无效组41只眼,由3名放射科医生基于25项MRI特征独立评估。

关键影像表现/征象

  • 多因素回归分析显示侧别、边缘及眼前段强化为预测静脉化疗疗效的独立因素。
  • 联合侧别、边缘及眼前段强化构建的预测模型以列线图可视化。

诊断标准与关键数值

  • 联合侧别、边缘及眼前段强化的预测模型AUC为0.732(95%CI:0.633,0.831,p<0.01),敏感度71.2%,特异度70.7%。

临床应用与阅片要点

  • 治疗前可基于眼眶MRI评估侧别、边缘及眼前段强化,用于预测静脉化疗疗效。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To investigate the value of orbital magnetic resonance imaging (MRI) features in predicting the efficacy of intravenous chemotherapy (IVC) for patients with retinoblastoma (RB).

MATERIALS AND METHODS: The pretreatment clinical and MRI data of 100 eyes from 80 RB patients who underwent IVC were collected retrospectively. There were 59 eyes in the effective group and 41 eyes in the ineffective group, and the baseline data of the two groups were compared statistically. Three radiologists reviewed and evaluated each lesion independently based on 25 MRI features. The predictive values of the MRI features for IVC efficacy were assessed by multi-factor logistic regression analysis, and their odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated. Receiver operating characteristic curves (ROCs) with the area under the curve (AUC) were used to determine the predictive abilities. A predictive model was constructed by integrating all independent predictors visualised by the nomogram.

RESULTS: There were no statistically significant differences in sex or age between the effective and ineffective groups. The results of multivariate regression analysis showed that laterality, margin, and anterior eye segment enhancement were identified as independent factors that could predict IVC efficacy. The predictive model combining these three features was constructed, and it had an AUC of 0.732 (95% CI: 0.633, 0.831, p<0.01), a sensitivity of 71.2%, and a specificity of 70.7%.

CONCLUSION: The data demonstrate that the orbital MRI features can be used to predict IVC efficiency before RB patients are treated.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Zhu X, Li Z, Liu J, et al. MRI features for prediction of the intravenous chemotherapy effect in patients with retinoblastoma. Clin Radiol. 2023. PMID: 37596180. doi:10.1016/j.crad.2023.07.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。